Hyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

Ten firms led a market rally with whopping gains on Thursday, outperforming the lackluster performance of the major indices ...

It’s no secret that prescription drugs can take a toll on your wallet. One classification of medication in particular—biologics—has had an oversized impact on the rising cost of prescription drugs.

The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a ...

Teva's innovative portfolio continues to drive strong performance and future potential. The company has announced its target ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 8.8% during the projected period. The ...

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...